Aspen Pharmaceuticals Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Durban South Africa (1850)
Status: No NME R&D (1850)

Organization Overview

First Clinical Trial
2013
NCT01828697
First Marketed Drug
1954
busulfan (myleran)
First NDA Approval
1954
busulfan (myleran)
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ASPEN | ASPEN GLOBAL | ASPEN GLOBAL INC | Aspen Global Incorporated | Aspen Pharma